A smart copper-phthalocyanine framework nanoparticle for enhancing photodynamic therapy in hypoxic conditions by weakening cells through ATP depletion
Gui, L (Gui, Li)[ 1 ] ; Zhou, JH (Zhou, Jiahong)[ 1 ] ; Zhou, L (Zhou, Lin)[ 1 ]*(周林); Wei, SH (Wei, Shaohua)[ 1 ]*(魏少華)
[ 1 ] Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Jiangsu Key Lab Biofunct Mat, Coll Chem & Mat Sci,Key Lab Appl Photochem, Nanjing 210023, Jiangsu, Peoples R China
JOURNAL OF MATERIALS CHEMISTRY B,201804,6(14),2078-2088
Hypoxia in solid tumors hinders the efficacy of photodynamic therapy (PDT). The route of generation of adenosine triphosphate (ATP) in hypoxic tumor cells comprises ineffective glycolysis processes, but ATP is crucial for rapid and uncontrolled growth and division. ATP depletion would inhibit DNA replication and glutathione (GSH) biosynthesis, which could inhibit the proliferation of cells and make them sensitive to PDT treatment. In this context, a nanoscale metal-organic framework nanoparticle consisting of Cu2+ and carboxyl-modified zinc phthalocyanine (ZnPc-(COOH)(8)) ({Cu-8(ZnPc-(COOH)(8))}(n), ZPCN) was designed and prepared. In the dark cycle, ATP could remove Cu2+ from ZPCN and form a copper-ATP complex. ATP in the above complex could be destroyed by a copper-mediated Fenton reaction, which could finally induce ATP depletion to inhibit the proliferation of cells and make them sensitive to PDT treatment. In the light cycle, ZPCN could generate abundant cytotoxic reactive oxygen species to suppress tumor growth. These results demonstrated the potential applicability of the new strategy for achieving tumor treatment in hypoxic conditions by PDT.
文章鏈接:
http://pubs.rsc.org/en/Content/ArticleLanding/2018/TB/C8TB00334C#!divAbstract
版權(quán)與免責(zé)聲明:本網(wǎng)頁(yè)的內(nèi)容由收集互聯(lián)網(wǎng)上公開(kāi)發(fā)布的信息整理獲得。目的在于傳遞信息及分享,并不意味著贊同其觀點(diǎn)或證實(shí)其真實(shí)性,也不構(gòu)成其他建議。僅提供交流平臺(tái),不為其版權(quán)負(fù)責(zé)。如涉及侵權(quán),請(qǐng)聯(lián)系我們及時(shí)修改或刪除。郵箱:sales@allpeptide.com